TOWARD, a metabolic health intervention, demonstrates robust 1-year weight loss and cost-savings through deprescription
Introduction Behavioral and lifestyle changes are considered a viable first-line treatment for diet-related noncommunicable diseases, including Type 2 Diabetes (T2D),...
